Greenlight XPS ® for the Treatment of Benign Prostatic Hyperplasia: our Experience and Real-World Results.
DOI:
https://doi.org/10.54212/27068048.v7i1.48Keywords:
Laser, Prostate, Transurethral, PhotovaporizationAbstract
Introduction: GreenLight Laser vaporization of the prostate was introduced in our institution more than five years ago as part of the surgical treatment options for obstructive benign prostatic hyperplasia.
Methods: This is an observational real world experience study (RWEs). We collected the data of 30 consecutive cases of GreenLight XPS prostate Photovaporization. Preoperative characteristics, surgery data and postoperative functional uroflowmetry and IPSS questionnaires were applied in a first follow up visit at two months.
Results: Mean age was 68.1 years. Four patients were in retention with permanent catheter. Uroflowmetry was performed in 20 patients with an average Qmax of 12.78 ml/s and Qave of 5.93ml/s. All patients were spontaneously urinating after post operatory catheter removal and Qmax and Qave at the second month was 20.73 and 9.90 ml/s respectively. IPSS showed 10 points improvement in the follow up visit and 83% of the patients were treated as outpatients with less than 24 hours of hospital stay.
Conclusions: This is the first report of the results with GreenLight XPS in our institution, this data shows that is a well-tolerated and effective method for surgical approach of benign prostatic hyperplasia, and can be safely perform as an outpatient in more than 80% of the cases.
Downloads
References
Isaacs JT, Coffey DS. Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl. 1989;2(Suppl):33-50. https://doi.org/10.1002/pros.2990150506 DOI: https://doi.org/10.1002/pros.2990150506
Barry MJ. Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am. 1990;17(3):495-507. https://doi.org/10.1016/S0094-0143(21)00963-0 DOI: https://doi.org/10.1016/S0094-0143(21)00963-0
Hollingsworth JM, Wei JT. Economic impact of surgical intervention in the treatment of benign prostatic hyperplasia. Rev Urol. 2006;8(Suppl 3):S9-S15.
Reich O, Gratzke C, Stief CG. Techniques and long-term results of surgical procedures for BPH. Eur Urol 2006;49:970-978. https://doi.org/10.1016/j.eururo.2005.12.072 DOI: https://doi.org/10.1016/j.eururo.2005.12.072
American Urological Association Education and Research Inc. American Urological Association Guideline: Management of benign prostatic hyperplasia (BPH) 2010. http://www.auanet.org/benign-prostatic-hyperplasia-(2010-reviewed-and-validity-confirmed-2014)
Gravas S, Bachmann A, Descazeaud A, Drake M, Gratzke C, Madersbacher S, et al. Guidelines on the management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO). EAU 2014.
Gratzke C, Bachmann A, Descazeaud A, et al. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2015;67:1099-109. https://doi.org/10.1016/j.eururo.2014.12.038 DOI: https://doi.org/10.1016/j.eururo.2014.12.038
Thomas JA, Tubaro A, Barber N, et al. A multicentre randomized non-inferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: Two-year outcomes of the GOLIATH study. Eur Urol. 2016;69:94-102.
https://doi.org/10.1016/j.eururo.2015.07.054 DOI: https://doi.org/10.1016/j.eururo.2015.07.054
Chughtai B, Te A. Photoselective vaporization of the prostate for treating benign prostatic hyperplasia. Expert Rev Med Devices. 2011.
https://doi.org/10.1586/erd.11.25 DOI: https://doi.org/10.1586/erd.11.25
Muller G, Bachmann A, Wyler SF. Vaporization techniques for benign prostatic obstruction: GreenLight all the way? Curr Opin Urol. 2014;24:42-8. https://doi.org/10.1097/MOU.0000000000000016 DOI: https://doi.org/10.1097/MOU.0000000000000016
Thangasamy IA, Chalasani V, Bachmann A, et al. Photoselective vaporisation of the prostate using 80-W and 120-W laser vs. transurethral resection of the prostate for benign prostatic hyperplasia: A systematic review with meta-analysis from 2002 to 2012. Eur Urol. 2012;62:315-23. https://doi.org/10.1016/j.eururo.2012.04.051 DOI: https://doi.org/10.1016/j.eururo.2012.04.051
Hueber PA, Liberman D, Ben-Zvi T, et al. 180 W vs 120 W lithium triborate photoselective vaporization of the prostate for benign prostatic hyperplasia: A global, multicentre comparative analysis of perioperative treatment parameters. Urology. 2013;82:1108-13. https://doi.org/10.1016/j.urology.2013.03.059 DOI: https://doi.org/10.1016/j.urology.2013.03.059
Altay B, Erkurt B, Kiremit MC, et al. 180-W XPS GreenLight laser vaporization for benign prostate hyperplasia: 12-month safety and efficacy results for glands larger than 80 mL. Lasers Med Sci. 2015;30:317-23. https://doi.org/10.1007/s10103-014-1667-4 DOI: https://doi.org/10.1007/s10103-014-1667-4
Brunken C, Seitz C, Woo HH. A systematic review of experience of 180-W XPS GreenLight laser vaporisation of the prostate in 1640 men. BJU Int. 2015;116:531-7. https://doi.org/10.1111/bju.12955 DOI: https://doi.org/10.1111/bju.12955
Castellan P, Castellucci R, Schips L, et al. Safety, efficacy, and reliability of 180-W GreenLight laser technology for prostate vaporization: Review of the literature. World J Urol. 2015;33:599-607. https://doi.org/10.1007/s00345-015-1490-y DOI: https://doi.org/10.1007/s00345-015-1490-y
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Alejandro Manduley, José R. Arosemena, Carlos Marín, Ricardo Donderis, Manuel Guerra, Florín Rotar, Jean García
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
